Cancer screening device developer Mirxes Holding has won approval from Beijing to launch a gastric cancer test, the first blood…
Read More »Mirxes
Hong Kong’s vast lead over Singapore as a listing venue appears unassailable, with even the Southeast Asian city’s home-grown companies…
Read More »
Initial public offering (IPO) plans keep rolling in for Hong Kong’s revitalised capital market, with China’s largest pharmaceutical company launching…
Read More »